TDM for monoclonal antibodies (Abs)- prospects based on progress of analytical methods
-
Session description:
Chairs: Kim Brøsen and Ulf Simonsen
TDM for monoclonal antibodies (Abs)- prospects based on progress of analytical methods
Silje Skrede, Norway
Supported by "Basic & Clinical Pharmacology & Toxicology"